Cargando…
Evaluating blood levels of neuron specific enolase, chromogranin A, and circulating tumor cells as Merkel cell carcinoma biomarkers
BACKGROUND: Merkel cell carcinoma (MCC) is a rare, aggressive neuroendocrine skin cancer. Although used to monitor MCC patients, the clinical utility of neuron-specific enolase (NSE) and chromogranin A (ChrA) blood levels is untested. EpCAM-positive circulating tumor cells (CTC) reflect disease stat...
Autores principales: | Gaiser, Maria Rita, Daily, Kenneth, Hoffmann, Jochen, Brune, Maik, Enk, Alexander, Brownell, Isaac |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4694915/ https://www.ncbi.nlm.nih.gov/pubmed/26299616 |
Ejemplares similares
-
Neuron-specific enolase and chromogranin A as markers of neuroendocrine tumours.
por: Baudin, E., et al.
Publicado: (1998) -
Assessment of Cancer Cell Line Representativeness using Microarrays for Merkel Cell Carcinoma
por: Daily, Kenneth, et al.
Publicado: (2014) -
Clinical significance of progastrin-releasing peptide, neuron-specific enolase, chromogranin a, and squamous cell cancer antigen in pulmonary neuroendocrine tumors
por: TUTAR, Nuri, et al.
Publicado: (2019) -
Challenges documenting racial disparities in Merkel cell carcinoma
por: Martin, Mackenzie R., et al.
Publicado: (2022) -
Prognostic value of circulating chromogranin A levels in acute coronary syndromes
por: Jansson, Anna M., et al.
Publicado: (2009)